0.7433
Biodesix Inc stock is traded at $0.7433, with a volume of 235.17K.
It is down -4.83% in the last 24 hours and down -22.81% over the past month.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
See More
Previous Close:
$0.781
Open:
$0.77
24h Volume:
235.17K
Relative Volume:
0.68
Market Cap:
$108.51M
Revenue:
$49.09M
Net Income/Loss:
$-52.15M
P/E Ratio:
-1.1435
EPS:
-0.65
Net Cash Flow:
$-45.93M
1W Performance:
-12.55%
1M Performance:
-22.81%
6M Performance:
-58.01%
1Y Performance:
-49.44%
Biodesix Inc Stock (BDSX) Company Profile
Name
Biodesix Inc
Sector
Industry
Phone
303-417-0500
Address
919 WEST DILLON ROAD, LOUISVILLE
Compare BDSX with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
BDSX
Biodesix Inc
|
0.7433 | 108.51M | 49.09M | -52.15M | -45.93M | -0.65 |
![]()
TMO
Thermo Fisher Scientific Inc
|
508.90 | 191.99B | 42.88B | 6.34B | 7.27B | 16.53 |
![]()
DHR
Danaher Corp
|
204.09 | 145.87B | 23.88B | 3.90B | 5.30B | 5.28 |
![]()
A
Agilent Technologies Inc
|
117.33 | 33.47B | 6.53B | 1.26B | 1.31B | 4.35 |
![]()
IDXX
Idexx Laboratories Inc
|
406.29 | 33.04B | 3.90B | 887.87M | 798.08M | 10.67 |
![]()
IQV
Iqvia Holdings Inc
|
181.43 | 31.99B | 15.41B | 1.37B | 2.11B | 7.50 |
Biodesix Inc Stock (BDSX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Sep-16-24 | Initiated | Scotiabank | Sector Outperform |
Jul-26-24 | Initiated | Craig Hallum | Buy |
May-13-24 | Initiated | TD Cowen | Buy |
May-03-24 | Initiated | Lake Street | Buy |
Nov-17-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Nov-23-20 | Initiated | BTIG Research | Buy |
Nov-23-20 | Initiated | Canaccord Genuity | Buy |
Nov-23-20 | Initiated | Morgan Stanley | Overweight |
Nov-23-20 | Initiated | William Blair | Outperform |
View All
Biodesix Inc Stock (BDSX) Latest News
Q1 Earnings Estimate for Biodesix Issued By William Blair - MarketBeat
Biodesix's (BDSX) "Outperform" Rating Reaffirmed at William Blair - MarketBeat
Biodesix (NASDAQ:BDSX) Issues Quarterly Earnings Results - MarketBeat
Q1 Earnings Forecast for Biodesix Issued By William Blair - Defense World
Biodesix (BDSX) Upgraded to Buy: What Does It Mean for the Stock? - MSN
Biodesix improved sales, cut losses in fourth quarter, fiscal 2024 - BizWest
Biodesix at TD Cowen Conference: Transformative Year Ahead - Investing.com
Analysts Have Been Trimming Their Biodesix, Inc. (NASDAQ:BDSX) Price Target After Its Latest Report - Yahoo Finance
William Blair Estimates Biodesix’s Q1 Earnings (NASDAQ:BDSX) - Defense World
It's Down 30% But Biodesix, Inc. (NASDAQ:BDSX) Could Be Riskier Than It Looks - Simply Wall St
Biodesix (NASDAQ:BDSX) Receives “Outperform” Rating from William Blair - Defense World
Biodesix, Inc. Reports Strong Growth Amid Financial Challenges - TipRanks
Positive Outlook for Biodesix: Buy Rating Supported by Salesforce Improvements and Revenue Growth Opportunities - TipRanks
Earnings call transcript: Biodesix Q4 2024 beats revenue expectations By Investing.com - Investing.com South Africa
Observations on the Biodesix Inc (NASDAQ:BDSX) Growth Curve - US Post News
Biodesix, Inc. (NASDAQ:BDSX) Q4 2024 Earnings Call Transcript - MSN
Biodesix: Strong Growth and Promising Future with Buy Rating from Kyle Mikson CFA - TipRanks
US Futures Tumble As Traders Await Trump's Congress Address: 'Volatility Is Certainly Being Fed By Trump 2.0 Moves,' Says ExpertCrowdStrike Holdings (NASDAQ:CRWD), Biodesix (NASDAQ:BDSX) - Benzinga
Biodesix, Inc. (BDSX): Among Penny Stocks with Insider Buying in 2025 - Insider Monkey
12 Penny Stocks with Insider Buying in 2025 - Insider Monkey
Biodesix Inc (BDSX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
Biodesix Inc (BDSX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Biodesix Reports Strong 2024 Financial Performance - TipRanks
Biodesix Inc reports results for the quarter ended December 31Earnings Summary - TradingView
BIODESIX Earnings Results: $BDSX Reports Quarterly Earnings - Nasdaq
Earnings call transcript: Biodesix Q4 2024 beats revenue expectations - Investing.com
Biodesix earnings beat by $0.01, revenue topped estimates - Investing.com Canada
Earnings Flash (BDSX) BIODESIX INC. Reports Q4 Revenue $20.4M, vs. FactSet Est of $19.9M - Marketscreener.com
Biodesix Announces Fourth Quarter and Fiscal Year 2024 Results - GlobeNewswire
Biodesix chief accounting officer Chris Vazquez sells $3,354 in stock - MSN
Biodesix (BDSX) Expected to Announce Quarterly Earnings on Monday - Defense World
Biodesix Inc expected to post a loss of 7 cents a shareEarnings Preview - TradingView
Biodesix Inc (BDSX) Q4 2024: Everything You Need To Know Ahead O - GuruFocus.com
Biodesix Inc (BDSX) Q4 2024: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Biodesix (BDSX) to Release Earnings on Monday - MarketBeat
Biodesix to Present at TD Cowen 45th Annual Health Care Conference - The Manila Times
Biodesix Leadership to Share Company Vision at Major Healthcare ConferenceWhat Will They Reveal? - StockTitan
Financial Analysis: Biodesix (NASDAQ:BDSX) versus First Choice Healthcare Solutions (OTCMKTS:FCHS) - Defense World
Insiders are the top stockholders in Biodesix, Inc. (NASDAQ:BDSX), and the recent 10% drop might have disappointed them - Simply Wall St
Biodesix, Inc. to Release Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025 - Nasdaq
Biodesix to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025 - GlobeNewswire
Insider Selling: Biodesix, Inc. (NASDAQ:BDSX) CEO Sells 83,660 Shares of Stock - MarketBeat
Biodesix, Inc. (NASDAQ:BDSX) Insider Gary Anthony Pestano Sells 16,748 Shares - MarketBeat
Biodesix, Inc. (NASDAQ:BDSX) CFO Robin Harper Cowie Sells 24,664 Shares - MarketBeat
Biodesix Inc Stock (BDSX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):